Open AccessHFA of the ESC Position paper on the management of LVAD supported patients for the non LVAD specialist healthcare provider Part 1: Introduction and at the non‐hospital settings in the community
Author(s) -
Ben Avraham Binyamin,
CrespoLeiro Marisa Generosa,
Filippatos Gerasimos,
Gotsman Israel,
Seferovic Petar,
Hasin Tal,
Potena Luciano,
Milicic Davor,
Coats Andrew J.S.,
Rosano Giuseppe,
Ruschitzka Frank,
Metra Marco,
Anker Stefan,
Altenberger Johann,
Adamopoulos Stamatis,
Barac Yaron D.,
Chioncel Ovidiu,
De Jonge Nicolaas,
Elliston Jeremy,
Frigeiro Maria,
Goncalvesova Eva,
Grupper Avishay,
Hamdan Righab,
Hammer Yoav,
Hill Loreena,
Itzhaki Ben Zadok Osnat,
Abuhazira Miriam,
Lavee Jacob,
Mullens Wilfried,
Nalbantgil Sanemn,
Piepoli Massimo F.,
Ponikowski Piotr,
Ristic Arsen,
Ruhparwar Arjang,
Shaul Aviv,
Tops Laurens F.,
Tsui Steven,
Winnik Stephan,
Jaarsma Tiny,
Gustafsson Finn,
Ben Gal Tuvia
Publication year - 2021
Publication title -
esc heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.787
H-Index - 25
ISSN - 2055-5822
DOI - 10.1002/ehf2.13588
Subject(s) - medicine , ventricular assist device , heart failure , emergency department , population , medical emergency , trilogy , health care , intensive care medicine , emergency medicine , nursing , art , environmental health , literature , economics , economic growth
The accepted use of left ventricular assist device (LVAD) technology as a good alternative for the treatment of patients with advanced heart failure together with the improved survival of the LVAD‐supported patients on the device and the scarcity of donor hearts has significantly increased the population of LVAD‐supported patients. The expected and non‐expected device‐related and patient–device interaction complications impose a significant burden on the medical system exceeding the capacity of the LVAD implanting centres. The ageing of the LVAD‐supported patients, mainly those supported with the ‘destination therapy’ indication, increases the risk for those patients to experience comorbidities common in the older population. The probability of an LVAD‐supported patient presenting with medical emergency to a local emergency department, internal, or surgical ward of a non‐LVAD implanting centre is increasing. The purpose of this trilogy is to supply the immediate tools needed by the non‐LVAD specialized physician: ambulance clinicians, emergency ward physicians, general cardiologists, internists, anaesthesiologists, and surgeons, to comply with the medical needs of this fast‐growing population of LVAD‐supported patients. The different issues discussed will follow the patient's pathway from the ambulance to the emergency department and from the emergency department to the internal or surgical wards and eventually to the discharge home from the hospital back to the general practitioner. In this first part of the trilogy on the management of LVAD‐supported patients for the non‐LVAD specialist healthcare provider, after the introduction on the assist devices technology in general, definitions and structured approach to the assessment of the LVAD‐supported patient in the ambulance and emergency department is presented including cardiopulmonary resuscitation for LVAD‐supported patients.